Year: 2026
NorthSea Therapeutics announces late breaking oral presentation of Phase 2 topline data of Orziloben in Intestinal Failure-Associated Liver Disease at AASLD The Liver Meeting® 2026
NorthSea Therapeutics B.V. (“NorthSea” or the “Company”) is a private, late-stage clinical biotechnology company leveraging its proprietary SEFA™ platform to develop novel drugs addressing the multiple pathways implicated in rare heterogenous liver diseases. NorthSea has announced that an abstract on topline data from its Phase 2 study of orziloben (NST-6179)
Read More
onsemi to acquire Ferric, establishing leadership in power delivery for next-generation AI processors
onsemi (Nasdaq: ON) has announced that it has entered into an agreement to acquire Ferric, Inc., an innovator in integrated voltage regulator (IVR) technology, for $600 million in cash, plus up to $175 million in contingent consideration upon achievement of certain revenue milestones. The acquisition will strengthen onsemi's leadership in
Read More
PlanetiQ expands GNSS-RO coverage with second satellite launch this month
PlanetiQ, a commercial provider of GNSS radio occultation (GNSS-RO) weather data, has announced that its GNOMES-11 satellite was successfully launched and deployed into orbit on SpaceX’s Bandwagon-5 mission. The satellite lifted off from NASA’s Kennedy Space Center in Florida at 7:04 a.m. EDT on October 20. GNOMES-11 has established contact
Read More
Promaxo lands $100M credit facility and Series C for MRI prostate platform
Promaxo has announced the initial close of its Series C financing, with participation from New Science Ventures and Amara Ventures, as well as the successful closing of a $100M credit facility. The new capital will support expanded manufacturing capacity, backlog reduction, and new regulatory filings. The growth capital provides Promaxo
Read More
Long Wall announces $75 million award from the Missile Defense Agency for Cyclops low-cost interceptor
Long Wall has announced a $75 million award from the Missile Defense Agency to complete flight testing of the Cyclops low-cost interceptor. Long Wall began development of Cyclops in 2024 and announced the product in December of last year. “Demand for interceptors has surged, while low production capacity and high
Read More
Resolve Therapeutics presents preclinical data on NET degradation and nuclease therapy in acute ischemic stroke at the World Stroke Conference
Resolve Therapeutics, LLC, a clinical-stage biotechnology company developing nuclease-Fc fusion proteins designed to degrade pathogenic extracellular nucleic acids, has announced two e-posters featuring preclinical data on its RNase-Fc fusion protein RSLV-132 and its bispecific RNase/DNase-Fc fusion protein RSLV-145 at the 18th World Stroke Congress, held October 21-23, 2026, in Seoul,
Read More
PlanetiQ launches GNOMES-10, expanding High-Precision GNSS Radio Occultation Constellation
PlanetiQ’s GNOMES-10 satellite successfully launched October 1 at 11:32 a.m. PDT aboard SpaceX’s Transporter-18 mission from Vandenberg Space Force Base, marking another major step in the company’s expansion of its global GNSS radio occultation (GNSS-RO) constellation. Following launch, PlanetiQ’s partner ground stations quickly established first contact with GNOMES-10, and spacecraft
Read More
RTA launches trial operation of Dubai Glydways Automated Transit System at Bluewaters
Dubai’s Roads and Transport Authority (RTA) has launched the trial operation of the Dubai Glydways automated transit system at Bluewaters. The system uses autonomous electric vehicles supported by artificial intelligence technologies, operating on dedicated guideways. The initiative marks a new step in RTA’s efforts to develop a smart, integrated and
Read More
Microchip Technology acquires VORAGO Technologies
Microchip Technology Incorporated (Nasdaq: MCHP), a broadline supplier of semiconductors committed to making innovative design easier through total system solutions, has announced that it has acquired VORAGO Technologies, Inc., a privately held provider of radiation-hardened and radiation-tolerant microcontrollers (MCUs) and microprocessors (MPUs), based in Austin, Texas. Terms of the transaction
Read More
Resolve Therapeutics completes enrollment in Phase 2 study of RSLV-132 in Sjögren’s Disease
Resolve Therapeutics, a clinical-stage biopharmaceutical company developing non-immunosuppressive therapies for autoimmune diseases, has announced the completion of enrollment in its Phase 2 study of RSLV-132 in women with Sjögren’s disease and moderate-to-severe symptom burden. The study enrolled approximately 110 participants at clinical sites across the United States. The multicenter, randomized,
Read More
PlanetiQ awarded $3.3 million for GNSS-PRO and Ionospheric TEC data
PlanetiQ has announced that NASA has awarded the company a $3.3 million task order to provide GNSS Polarimetric Radio Occultation (GNSS-PRO) and ionospheric Total Electron Content (TEC) data through NASA’s Commercial Satellite Data Acquisition (CSDA) program. The acquisition will provide NASA researchers with high-SNR observations of precipitation and the ionosphere.
Read More
VOLLO sets new STAC-ML records for gradient-boosted tree inference
Myrtle.ai has announced that its VOLLO® inference accelerator has set new records on the STAC-ML Markets (Inference) benchmarks for gradient-boosted trees, cutting 99th-percentile latency by more than 30% and raising throughput by at least 5x over the previous best results. The STAC®-audited results were unveiled at the STAC Summit in
Read More